Physician profile
Amy Chai
NPI 1710399548
$1,083.89
in general payments reported to CMS, 2019-2025
21 companies · $20.31 in 2025
The $20.31 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $184 · 2025: $20.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $253.23 | 2019-2020 | |
| Mdd US Operations, LLC | $127.71 | 2019 | |
| Indivior INC. | $110.83 | 2019-2025 | Sublocade |
| Astellas Pharma US INC | $76.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $73.15 | 2019 | |
| Orexo US, INC. | $57.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.16 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $55.37 | 2019-2020 | |
| Pfizer INC. | $36.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $35.01 | 2019-2020 | |
| Photocure INC | $33.18 | 2020 | |
| Medtronic Vascular, INC. | $24.77 | 2020 | |
| Genentech USA, INC. | $20.77 | 2019 | |
| Amarin Pharma, INC. | $18.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.40 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.17 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.21 | 2019 | |
| Glaxosmithkline, LLC. | $15.48 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.90 | 2019 | |
| Lilly USA, LLC | $13.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Chai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.